Analysis of the interactions between MF-C1-TDO2 myofibroblasts and CD8+ T or CD4+ T cells using the CellPhoneDB revealed that, in comparison with MF-C2-ELN myofibroblasts, MF-C1-TDO2 myofibroblasts in tumor tissue had stronger chemotaxis toward both CD8+ T cells and CD4+ T cells (Figure 5A). This evidence concerns the gene CD4 and neoplasm.